{"title":"Testes urinários Drugdiag® T","description":"\u003csection class=\"ama-collection-description\"\u003e\n \u003ch2\u003eTestes urinários de despiste de drogas\u003c\/h2\u003e\n\n \u003cp\u003e\n Os \u003cstrong\u003etestes urinários de despiste de drogas\u003c\/strong\u003e oferecidos pela \u003cstrong\u003eAMA Prévention\u003c\/strong\u003e\n permitem detetar rapidamente várias famílias de substâncias psicoativas a partir de uma amostra de urina.\n São adequados às necessidades de \u003cstrong\u003eparticulares\u003c\/strong\u003e, \u003cstrong\u003eempresas\u003c\/strong\u003e,\n \u003cstrong\u003eprofissionais de saúde\u003c\/strong\u003e, \u003cstrong\u003ecoletividades\u003c\/strong\u003e e estruturas que pretendam implementar\n uma abordagem de prevenção fiável, simples e acessível.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Conforme o modelo, os nossos testes urinários podem detetar \u003cstrong\u003eTHC\u003c\/strong\u003e,\n \u003cstrong\u003ecocaína\u003c\/strong\u003e, \u003cstrong\u003eanfetaminas\u003c\/strong\u003e, \u003cstrong\u003emetanfetaminas\u003c\/strong\u003e,\n \u003cstrong\u003eopiáceos\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003ebenzodiazepinas\u003c\/strong\u003e,\n \u003cstrong\u003emetadona\u003c\/strong\u003e, \u003cstrong\u003ebuprenorfina\u003c\/strong\u003e, \u003cstrong\u003ebarbitúricos\u003c\/strong\u003e,\n \u003cstrong\u003eantidepressivos tricíclicos\u003c\/strong\u003e ou ainda algumas \u003cstrong\u003enovas substâncias psicoativas\u003c\/strong\u003e,\n conforme a referência escolhida.\n \u003c\/p\u003e\n\n \u003ch3\u003eDrugdiag® T: um formato urinário prático e económico\u003c\/h3\u003e\n\n \u003cp\u003e\n O \u003cstrong\u003eteste urinário Drugdiag® T\u003c\/strong\u003e é um teste para mergulhar diretamente na amostra de urina.\n As zonas reativas localizadas na parte inferior do dispositivo permitem uma leitura clara e rápida\n dos resultados. Este formato é particularmente apreciado pela sua simplicidade,\n \u003cstrong\u003eeconómico\u003c\/strong\u003e e \u003cstrong\u003eprático\u003c\/strong\u003e, especialmente quando é necessário realizar vários despistes.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Conforme o modelo, a gama \u003cstrong\u003eDrugdiag® T\u003c\/strong\u003e permite despistar várias substâncias numa única análise,\n com versões adaptadas às necessidades comuns como o \u003cstrong\u003eteste urinário THC\u003c\/strong\u003e, o despiste multi-drogas,\n ou a pesquisa de substâncias específicas. Alguns modelos podem detetar até \u003cstrong\u003e13 substâncias\u003c\/strong\u003e,\n conforme a configuração do teste.\n \u003c\/p\u003e\n\n \u003ch3\u003eUma gama desenvolvida por um fabricante francês\u003c\/h3\u003e\n\n \u003cp\u003e\n Os testes urinários Drugdiag® são desenvolvidos pela \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, fabricante francês especializado\n em testes de diagnóstico rápido. A AMA Prévention seleciona estes dispositivos pela sua facilidade de utilização,\n legibilidade e adaptação aos usos profissionais e particulares.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Conforme as referências, alguns testes beneficiam de certificações ou menções específicas, nomeadamente o\n \u003cstrong\u003emarcador CE\u003c\/strong\u003e, conformidade com os padrões de fabrico aplicáveis, o \u003cstrong\u003elabel Alsace Cœur\u003c\/strong\u003e\n ou a menção \u003cstrong\u003eUtilizado pelas Forças Armadas Francesas\u003c\/strong\u003e quando aplicável ao produto em questão.\n \u003c\/p\u003e\n\n \u003ch3\u003eTestes urinários para particulares, empresas e profissionais\u003c\/h3\u003e\n\n \u003cp\u003e\n Os testes urinários de despiste são usados em muitos contextos: \u003cstrong\u003eautoavaliação\u003c\/strong\u003e,\n recuperação de carta, prevenção em empresas, acompanhamento em estruturas de saúde, ações de sensibilização,\n ou necessidade pontual de verificação. Permitem uma abordagem simples e rápida ao despiste, mantendo-se\n testes de orientação.\n \u003c\/p\u003e\n\n \u003cp\u003e\n Em ambiente profissional, a utilização de testes de despiste deve enquadrar-se numa estrutura clara, proporcional\n e conforme as regras aplicáveis, especialmente para postos de risco ou situações que possam comprometer\n a segurança das pessoas. A AMA Prévention acompanha as empresas na escolha dos testes mais adequados\n ao seu uso.\n \u003c\/p\u003e\n\n \u003ch3\u003eEncomende os seus testes urinários Drugdiag®\u003c\/h3\u003e\n\n \u003cp\u003e\n Encomende os seus \u003cstrong\u003etestes urinários THC\u003c\/strong\u003e, \u003cstrong\u003etestes urinários multi-drogas\u003c\/strong\u003e,\n \u003cstrong\u003etestes Drugdiag® T\u003c\/strong\u003e e testes urinários profissionais diretamente online na AMA Prévention.\n Envio rápido em 24h com DPD, serviço de apoio ao cliente eficiente e acompanhamento profissional para escolher\n a referência mais adequada à sua necessidade.\n \u003c\/p\u003e\n\n \u003cp\u003e\n \u003cstrong\u003e\n Para encomendas em volume, necessidades profissionais ou campanhas de prevenção,\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\"\u003epeça um orçamento personalizado à AMA Prévention\u003c\/a\u003e.\n \u003c\/strong\u003e\n \u003c\/p\u003e\n\u003c\/section\u003e","products":[{"product_id":"test-urinaire-3thc","title":"Teste Urinário THC (Cannabis) Drugdiag® T com 3 níveis de deteção","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 3THC urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário cannabis 3 limites\u003c\/span\u003e \u003ch2 class=\"ama-bsafe-title\"\u003e Drugdiag® 3THC: teste urinário cannabis com 3 limites \u003c\/h2\u003e \u003cp class=\"ama-bsafe-lead\"\u003e O \u003cstrong\u003eteste urinário cannabis Drugdiag® 3THC\u003c\/strong\u003e é um dispositivo profissional concebido pelo laboratório francês \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, nº1 em testes de diagnóstico rápido. A sua particularidade é detetar a cannabis em \u003cstrong\u003e3 níveis de sensibilidade\u003c\/strong\u003e numa única análise: \u003cstrong\u003e20 ng\/mL\u003c\/strong\u003e, \u003cstrong\u003e50 ng\/mL\u003c\/strong\u003e e \u003cstrong\u003e150 ng\/mL\u003c\/strong\u003e. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Este teste urinário de imersão permite avaliar de forma mais precisa o nível de impregnação em \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principal metabolito urinário da cannabis. É particularmente adequado para \u003cstrong\u003eacompanhamento médico\u003c\/strong\u003e, \u003cstrong\u003erecuperação da carta de condução\u003c\/strong\u003e, \u003cstrong\u003eautoavaliação\u003c\/strong\u003e e ações de prevenção em ambiente profissional. \u003c\/p\u003e \u003cp class=\"ama-bsafe-lead\"\u003e Graças à sua leitura tripla, o Drugdiag® 3THC ajuda a distinguir uma presença baixa, padrão ou elevada de metabolitos da cannabis na urina, com um resultado rápido e simples de interpretar segundo as instruções do fabricante. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003e3 limites: 20, 50 e 150 ng\/mL\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDeteção urinária do THC-COOH\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eIdeal para acompanhamento, carta de condução e autoavaliação\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e3 limites THC-COOH\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstância detetada e limites\u003c\/h2\u003e \u003cp\u003e O teste Drugdiag® 3THC procura o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principal metabolito da cannabis eliminado na urina. A leitura tripla permite obter uma indicação mais precisa do que um teste urinário clássico de cannabis com um único limite. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003e20 ng\/mL\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAlta sensibilidade:\u003c\/strong\u003e deteção de vestígios baixos de THC-COOH na urina, útil no final da eliminação ou para um acompanhamento muito detalhado.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eLimite baixo\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003e50 ng\/mL\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eLimite padrão:\u003c\/strong\u003e limite habitualmente usado para o rastreio urinário da cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eReferência\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003e150 ng\/mL\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eConcentração elevada:\u003c\/strong\u003e indicação possível de um consumo mais intenso, regular ou crónico.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003eLimite alto\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e Este teste urinário não procura diretamente o Δ9-THC ativo na saliva. Procura o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, metabolito urinário da cannabis, o que permite uma janela de deteção mais longa. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-alert\"\u003e \u003ch3\u003eAtenção: CBD e possível positividade\u003c\/h3\u003e \u003cp\u003e O CBD puro não é o alvo do teste. No entanto, alguns produtos de CBD de espectro completo podem conter vestígios residuais de THC. \u003c\/p\u003e \u003cp\u003e Em caso de consumo repetido de flores, resinas ou óleos de CBD contendo THC residual, o THC pode ser metabolizado em \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e e provocar um resultado positivo na urina. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizações\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eCarta, acompanhamento, trabalho\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePor que usar um teste com 3 limiares?\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eRecuperação de carta de condução\u003c\/h3\u003e \u003cp\u003e O Drugdiag® 3THC é particularmente útil para acompanhar a eliminação progressiva do THC-COOH antes de uma consulta médica, uma comissão médica ou uma análise oficial. Os três limiares permitem observar uma diminuição do nível de deteção ao longo do tempo. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eUso profissional\u003c\/h3\u003e \u003cp\u003e Empresas, profissionais de saúde e agentes de prevenção podem usar este teste para dispor de uma ferramenta mais precisa do que um teste com limiar único, respeitando o quadro interno aplicável e a confidencialidade dos resultados. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eAcompanhamento médico e auto-controle\u003c\/h3\u003e \u003cp\u003e O teste pode acompanhar um acompanhamento de cessação, uma abordagem de prevenção ou um auto-controle rigoroso. Permite distinguir um traço baixo de uma concentração mais elevada de metabólitos urinários da cannabis. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003ePontos fortes do Drugdiag® 3THC\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eLeitura tripla :\u003c\/strong\u003e 20, 50 e 150 ng\/mL numa única análise.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eAnálise detalhada :\u003c\/strong\u003e acompanhamento progressivo da eliminação do THC-COOH na urina.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eJanela de deteção ampla :\u003c\/strong\u003e útil para procurar um consumo passado.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormato prático :\u003c\/strong\u003e teste urinário para imersão, simples e rápido de usar.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFabricante francês :\u003c\/strong\u003e dispositivo da gama Drugdiag® do laboratório Toda Pharma.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eQualidade profissional :\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE e ambiente de qualidade ISO 13485.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUtilizado pelas Forças Armadas Francesas :\u003c\/strong\u003e selo UAF associado aos dispositivos da gama Toda Pharma em questão.\u003c\/li\u003e \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eInterpretação dos limiares\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eInterpretação dos 3 limiares\u003c\/h2\u003e \u003cp\u003e Os limiares permitem avaliar o nível de deteção do THC-COOH. Não permitem, por si só, datar precisamente um consumo, mas dão uma indicação útil sobre o nível de impregnação urinária. \u003c\/p\u003e \u003cdiv class=\"ama-bsafe-substance-list\"\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003e20 ng\/mL\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eTraços baixos :\u003c\/strong\u003e pode indicar um consumo antigo, um fim de eliminação ou uma presença residual próxima do limiar baixo.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias*\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003e50 ng\/mL\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eLimiar padrão :\u003c\/strong\u003e indicação compatível com uma presença urinária mais significativa de metabólitos da cannabis.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 15 dias*\u003c\/span\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-substance-row\"\u003e \u003cspan class=\"ama-bsafe-substance-code\"\u003e150 ng\/mL\u003c\/span\u003e \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eConcentração elevada:\u003c\/strong\u003e pode ser compatível com consumo recente, intenso, regular ou crónico.\u003c\/div\u003e \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 dias*\u003c\/span\u003e \u003c\/div\u003e \u003c\/div\u003e \u003cp class=\"ama-bsafe-note\"\u003e *Os períodos são indicativos e variam muito conforme o metabolismo, frequência de consumo, concentração dos produtos, IMC, hidratação e outros fatores individuais. \u003c\/p\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eResultado negativo\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um resultado negativo significa que o limite em questão não foi atingido. Segundo as três tiras, é possível obter uma indicação graduada da eliminação do THC-COOH. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eResultado positivo apenas em 20 ng\/mL\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Isso pode indicar uma presença baixa de THC-COOH, frequentemente compatível com o fim da eliminação. A interpretação deve ser cautelosa e considerar o contexto. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eResultado positivo em 50 ou 150 ng\/mL\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Quanto maior o limite positivo, maior a concentração urinária detectada. Para qualquer procedimento oficial, médico ou contestado, recomenda-se confirmação laboratorial. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualidade e confiabilidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e \u003cdiv class=\"ama-bsafe-grid\"\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e \u003cp\u003e O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal, permitindo uma leitura clara, rápida e adequada para usos profissionais. \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eConfiabilidade GC\/MS\u003c\/h3\u003e \u003cp\u003e A precisão deste dispositivo profissional de rastreio urinário foi comparada ao método de referência laboratorial, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e). \u003c\/p\u003e \u003c\/article\u003e \u003carticle class=\"ama-bsafe-card\"\u003e \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e \u003cp\u003e Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e e um sistema de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/article\u003e \u003c\/div\u003e \u003ch3\u003ePrincipais características\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eTipo de teste:\u003c\/strong\u003e teste urinário de cannabis para imersão.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstância pesquisada:\u003c\/strong\u003e THC-COOH, metabolito urinário da cannabis.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eLimites:\u003c\/strong\u003e 20 ng\/mL, 50 ng\/mL e 150 ng\/mL.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eFormato:\u003c\/strong\u003e teste urinário multi-limite embalado individualmente.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eConteúdo:\u003c\/strong\u003e 1 teste urinário multi-limite e instruções de uso em francês na embalagem.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eUso:\u003c\/strong\u003e acompanhamento médico, recuperação de carta, autoavaliação e prevenção profissional.\u003c\/li\u003e \u003c\/ul\u003e \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e \u003cul class=\"ama-bsafe-list\"\u003e \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e \u003c\/ul\u003e \u003cp class=\"ama-bsafe-note\"\u003e O teste deve ser utilizado conforme o manual do fabricante. Em caso de resultado positivo, duvidoso ou contestado, recomenda-se confirmação por análise laboratorial. \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e \u003cdiv class=\"ama-inner-accordion\"\u003e \u003cdetails open\u003e \u003csummary\u003eO que deteta o teste Drugdiag® 3THC?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Deteta o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, principal metabolito urinário do cannabis, em três limiares diferentes: \u003cstrong\u003e20 ng\/mL\u003c\/strong\u003e, \u003cstrong\u003e50 ng\/mL\u003c\/strong\u003e e \u003cstrong\u003e150 ng\/mL\u003c\/strong\u003e. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQual é a diferença em relação a um teste urinário THC clássico?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Um teste clássico funciona geralmente com um limiar único. O Drugdiag® 3THC permite uma leitura graduada graças a três limiares, o que ajuda a acompanhar a evolução da eliminação. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eEste teste é adequado para a recuperação da carta de condução?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sim. É particularmente útil para o auto controlo antes de uma consulta médica ou análise oficial, pois permite acompanhar mais precisamente a presença residual de THC-COOH. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eO CBD pode tornar este teste positivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Sim, em alguns casos. O CBD puro não é o alvo do teste, mas produtos de CBD contendo THC residual podem causar positividade urinária após metabolização em THC-COOH. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eQuanto tempo o cannabis permanece detetável na urina?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e A duração varia conforme o perfil. Pode ir de alguns dias em uso ocasional a várias semanas em caso de uso regular ou crónico. Os limiares 20, 50 e 150 ng\/mL permitem obter uma indicação mais graduada. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003cdetails\u003e \u003csummary\u003eUm resultado positivo tem valor legal definitivo?\u003c\/summary\u003e \u003cdiv class=\"ama-accordion-content\"\u003e \u003cp\u003e Não. Um teste rápido fornece um resultado preliminar. Para qualquer procedimento oficial, médico ou contestado, recomenda-se uma confirmação por método analítico laboratorial. \u003c\/p\u003e \u003c\/div\u003e \u003c\/details\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-cta\"\u003e \u003cp\u003ePrecisa de aconselhamento ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e Pedir um orçamento \u003c\/a\u003e \u003c\/div\u003e \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e \u003cp\u003e \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação CE. Fornece um resultado analítico preliminar destinado a detectar de forma indicativa a presença de \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e na urina. Não constitui uma prova legal definitiva e não substitui uma análise toxicológica laboratorial. Em caso de tratamento médico, resultado positivo, dúvida ou situação oficial, consulte um profissional de saúde ou um laboratório de análises médicas. \u003c\/p\u003e \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426434330948,"sku":"1041-3THC","price":10.9,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426434363716,"sku":"1041-3THC","price":54.5,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426434429252,"sku":"1041-3THC","price":231.62,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 8","offer_id":56557345571140,"sku":"3THC-T-8","price":82.84,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_du_drugdiag_3THC.png?v=1777888468"},{"product_id":"test-urinaire-a-tremper-2-drogues","title":"Teste Urinário THC (Cannabis) e Cocaína Drugdiag® 2T","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Test Urinaire THC (Cannabis) et Cocaïne Drugdiag® 2T\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário profissional\u003c\/span\u003e\n \u003ch2 class=\"ama-bsafe-title\"\u003eTeste Urinário THC (Canábis) e Cocaína Drugdiag® 2T\u003c\/h2\u003e\n \u003cdiv class=\"ama-bsafe-lead\"\u003e\n \u003cp style=\"font-size: 17px; line-height: 1.8; margin-bottom: 15px;\"\u003eEste \u003cstrong\u003eTeste Urinário Canábis \u0026amp; Cocaína\u003c\/strong\u003e é uma solução de rastreio por imersão, concebida e fabricada pelo laboratório \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, líder em diagnóstico rápido em França e na Europa. Conforme às exigências médicas rigorosas, permite uma deteção precisa do consumo de estupefacientes mesmo vários dias após a toma.\u003c\/p\u003e\n\u003cp style=\"font-size: 16px; line-height: 1.7; margin: 0;\"\u003eVersátil e fiável, responde perfeitamente às necessidades dos \u003cstrong\u003eprofissionais\u003c\/strong\u003e (medicina do trabalho, forças da ordem, associações) bem como dos \u003cstrong\u003eparticulares\u003c\/strong\u003e que desejam realizar um auto-controle no âmbito da recuperação da carta ou de um acompanhamento pessoal.\u003c\/p\u003e\n\u003ch3 style=\"color: #004C96;\"\u003e🧪 Moléculas detectadas com precisão:\u003c\/h3\u003e\n\u003cul\u003e\n \u003cli\u003e\n\u003cstrong\u003eCanábis (THC) :\u003c\/strong\u003e Detecção do Δ9-THC e seus metabolitos.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eCocaína (COC) :\u003c\/strong\u003e Detecção da Benzilecgonina.\u003c\/li\u003e\n\u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n \u003cdetails class=\"ama-bsafe-item\" open\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eAs aplicações deste teste de rastreio\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eAs aplicações deste teste de rastreio Medicina do Trabalho \u0026amp; Profissionais Uma ferramenta essencial…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eAs aplicações deste teste de rastreio\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n\u003cdiv class=\"ama-bsafe-card\"\u003e\n\u003ch3 style=\"margin-top: 0;\"\u003eMedicina do Trabalho \u0026amp; Profissionais\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0;\"\u003eUma ferramenta essencial para empregadores e serviços de saúde no trabalho. Permite agir preventivamente contra os riscos associados ao consumo de substâncias psicoativas em postos de risco (condução de máquinas, segurança).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"ama-bsafe-card\"\u003e\n\u003ch3 style=\"margin-top: 0;\"\u003eRecuperação da Carta\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 10px;\"\u003eIdeal para particulares em fase de recuperação da carta de condução. Este teste permite verificar por si mesmo, antes da consulta médica oficial, se os metabolitos (THC-COOH) foram eliminados do organismo.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"ama-bsafe-card\"\u003e\n\u003ch3 style=\"margin-top: 0;\"\u003eFiabilidade Toda Pharma\u003c\/h3\u003e\n\u003cp style=\"margin-bottom: 0;\"\u003eBeneficie da qualidade do N.º 1 francês. O nosso serviço de apoio ao cliente, sediado em Estrasburgo, está disponível 7 dias por semana para o ajudar na implementação de protocolos de rastreio fiáveis e conformes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePor que escolher este teste urinário?\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePor que escolher este teste urinário? Especialização Francesa : Fabricado pela Toda Pharma,…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePor que escolher este teste urinário?\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eEspecialização Francesa :\u003c\/strong\u003e Fabricado pela Toda Pharma, referência europeia em diagnóstico.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAlta Sensibilidade :\u003c\/strong\u003e Deteta resíduos mesmo em baixa concentração.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eDuplo Alvo :\u003c\/strong\u003e Análise simultânea de Cannabis (THC) e Cocaína (COC).\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eSimplicidade :\u003c\/strong\u003e Teste \"para mergulhar\" fácil de usar sem equipamento complexo.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePrevenção :\u003c\/strong\u003e Ferramenta eficaz contra comportamentos de risco e submissão química.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAcompanhamento :\u003c\/strong\u003e Suporte técnico especializado disponível permanentemente.\u003c\/li\u003e\n\u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eLimites de deteção e Substâncias\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eLimites de deteção e Substâncias Este dispositivo deteta os metabólitos específicos que…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eLimites de deteção e Substâncias\u003c\/h2\u003e\n\u003cp\u003eEste dispositivo deteta os metabólitos específicos que permanecem presentes na urina muito depois do desaparecimento dos efeitos psicotrópicos.\u003c\/p\u003e\n\u003ctable style=\"width: 100%;\" class=\"ama-bsafe-table\"\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth style=\"width: 40%;\"\u003eSubstância Alvo\u003c\/th\u003e\n\u003cth style=\"width: 60%;\"\u003eLimite de corte (Cut-off)\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eTHC-COOH (Cannabis)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e50 ng\/mL\u003cbr\u003e\u003cspan style=\"font-size: 0.9em; font-weight: normal;\"\u003eMetabólito detetável vários dias após o consumo.\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCOC (Cocaína)\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e300 ng\/mL\u003cbr\u003e\u003cspan style=\"font-size: 0.9em; font-weight: normal;\"\u003eDeteção fiável de cocaína (benzilecgonina).\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp class=\"ama-bsafe-note\"\u003eAo contrário dos testes salivares que detetam consumo imediato, o teste urinário permite rastrear um consumo mais antigo (janela de deteção alargada).\u003c\/p\u003e\n\u003cdiv class=\"ama-bsafe-alert\"\u003e\n\u003ch3\u003e⚠️ Informação Importante\u003c\/h3\u003e\n\u003cp\u003eEste teste é um dispositivo de diagnóstico in vitro destinado a uso profissional ou privado, em conformidade com as regulamentações vigentes.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNota :\u003c\/strong\u003e Um resultado positivo indica a presença de metabólitos de drogas na urina. Não indica o estado de intoxicação atual no momento do teste, mas prova um consumo passado. Para confirmação legal, recomenda-se uma análise laboratorial.\u003c\/p\u003e\n\u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eConteúdo do Kit de Teste\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eConteúdo do Kit de Teste O produto é entregue pronto a usar: Tira\/Cassete…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eConteúdo do Kit de Teste\u003c\/h2\u003e\n\u003cp\u003eO produto é entregue pronto a usar:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTira\/Cassete de teste urinário (THC + COC)\u003c\/li\u003e\n\u003cli\u003eSaco desidratante (para conservação)\u003c\/li\u003e\n\u003cli\u003eInstruções detalhadas de utilização em Francês\u003c\/li\u003e\n\u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eExpertise Clínica \u0026amp; Especificidade\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eExpertise Clínica \u0026amp; Especificidade Tecnologia Avançada com Ouro Coloidal Os nossos dispositivos…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise Clínica \u0026amp; Especificidade\u003c\/h2\u003e\n\u003ch3\u003eTecnologia Avançada com Ouro Coloidal\u003c\/h3\u003e\n\u003cp\u003eOs nossos dispositivos utilizam imunocromatografia por competição com anticorpos marcados com ouro coloidal, garantindo a aparição de uma marcação nítida, ultra-sensível e uma fiabilidade de nível médico.\u003c\/p\u003e\n\u003ch3\u003eFiabilidade certificada em Laboratório (GC\/MS)\u003c\/h3\u003e\n\u003cp\u003eA precisão deste dispositivo profissional de despistagem urinária foi rigorosamente validada por estudos clínicos comparativos. Os resultados demonstram uma correlação de exatidão \u003cstrong\u003esuperior a 99 %\u003c\/strong\u003e em relação ao método de referência mundial em laboratório (Cromatografia gasosa acoplada à espectrometria de massa - GC\/MS).\u003c\/p\u003e\n\u003ch3\u003eSelos de Qualidade Institucionais\u003c\/h3\u003e\n\u003cp\u003eConcebido e Fabricado em França pelo Laboratório Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e beneficia da certificação \u003cstrong\u003eISO 13485\u003c\/strong\u003e e da marcação \u003cstrong\u003eCE\u003c\/strong\u003e. O seu elevado nível de exigência vale-lhe a certificação pelo \u003cstrong\u003eLabel UAF (Utilizado pelas Forças Armadas Francesas)\u003c\/strong\u003e e o Label Cœur Alsace.\u003c\/p\u003e\n\u003ch3\u003eAusência de reações cruzadas (Falsos Positivos)\u003c\/h3\u003e\n\u003cp\u003eA elevada especificidade analítica da gama Toda Drugdiag® garante a ausência total de interferência (testada até uma concentração de 100 μg\/ml) com produtos de consumo corrente. \u003cstrong\u003eO resultado urinário não será falsificado\u003c\/strong\u003e pela presença de:\u003c\/p\u003e\n\u003cul\u003e\n \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns :\u003c\/strong\u003e Aspirina (Ácido acetilsalicílico), Ibuprofeno, Paracetamol (Acetaminofeno), Amoxicilina, Penicilina, xaropes antitússicos (Dextrometorfano).\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares :\u003c\/strong\u003e Cafeína, Colesterol, Hemoglobina, Creatinina, Vitamina C (Ácido ascórbico), Ácido úrico.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n\u003cp\u003e\u003cstrong\u003eAviso legal :\u003c\/strong\u003e Este dispositivo médico de diagnóstico in vitro é um produto de saúde regulamentado que, ao abrigo desta regulamentação, possui a marcação CE. Leia atentamente as instruções contidas na bula. Em caso de dúvida sobre o resultado, consulte um profissional de saúde.\u003c\/p\u003e\n\u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426434658628,"sku":"1042T-A","price":9.9,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426434691396,"sku":"1042T-A","price":49.5,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426434724164,"sku":"1042T-A","price":94.05,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426434756932,"sku":"1042T-A","price":210.38,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/Photo_produit_T_-_THC-COC.png?v=1777892099"},{"product_id":"test-urinaire-a-tremper-6-drogues","title":"Teste Urinário 6 Drogas Drugdiag® 6T","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 6T urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário por imersão para 6 drogas\u003c\/span\u003e\n \n \u003ch2 class=\"ama-bsafe-title\"\u003e\n Drugdiag® 6T: teste urinário por imersão para 6 drogas\n \u003c\/h2\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n O \u003cstrong\u003eteste urinário Drugdiag® 6T\u003c\/strong\u003e, concebido pelo \u003cstrong\u003elaboratório francês Toda Pharma\u003c\/strong\u003e, nº1 em testes de diagnóstico rápido, é um dispositivo de despiste urinário por imersão que permite a deteção simultânea de \u003cstrong\u003e6 famílias de substâncias psicoativas\u003c\/strong\u003e.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Procura as seguintes famílias: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e cannabis, \u003cstrong\u003eCOC\u003c\/strong\u003e cocaína, \u003cstrong\u003eAMP\u003c\/strong\u003e anfetaminas, \u003cstrong\u003eMET\u003c\/strong\u003e metanfetaminas, \u003cstrong\u003eMOP\u003c\/strong\u003e opiáceos naturais e \u003cstrong\u003eBZO\u003c\/strong\u003e benzodiazepinas.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Simples, rápido e fiável, este teste de imersão é adequado para \u003cstrong\u003eempresas\u003c\/strong\u003e, \u003cstrong\u003eprofissionais de saúde\u003c\/strong\u003e, \u003cstrong\u003eforças de segurança\u003c\/strong\u003e, estruturas de prevenção e \u003cstrong\u003eparticulares\u003c\/strong\u003e que queiram realizar um despiste urinário de forma responsável.\n \u003c\/p\u003e\n \n \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDeteção simultânea de 6 famílias\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFormato de imersão, simples e rápido\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eUso em saúde, empresa e prevenção\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e6 famílias alvo\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstâncias detetadas\u003c\/h2\u003e\n\n \u003cp\u003e\n O Drugdiag® 6T deteta 6 famílias de substâncias na urina. Este formato de imersão permite uma utilização simples, rápida e adequada para despistagens unitárias ou campanhas supervisionadas.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCannabis:\u003c\/strong\u003e metabólito urinário do THC, associado ao consumo de cannabis, resina, flores ou produtos contendo THC.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína:\u003c\/strong\u003e cocaína, crack e metabólitos relacionados detetáveis na urina.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e estimulantes do tipo anfetamínico, speed e substâncias relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e crystal meth, ice e derivados relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos naturais:\u003c\/strong\u003e morfina, heroína, ópio e compostos relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas:\u003c\/strong\u003e Valium®, Xanax®, Temesta®, Lexomil® e moléculas relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n O teste pode cobrir muitas moléculas associadas a estas famílias, nomeadamente cannabis, cocaína, opiáceos, anfetaminas, metanfetaminas e benzodiazepinas. Os resultados devem ser sempre interpretados segundo as instruções do fabricante e o contexto de utilização.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizações\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEmpresa, saúde, prevenção\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePrincipais utilizações\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePrevenção nas empresas\u003c\/h3\u003e\n \u003cp\u003e\n O Drugdiag® 6T pode ser integrado numa abordagem de prevenção de riscos em postos sensíveis, respeitando o quadro aplicável, o regulamento interno, a proporcionalidade e a confidencialidade dos resultados.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eProfissionais de saúde\u003c\/h3\u003e\n \u003cp\u003e\n Este teste para imersão é adequado para profissionais de saúde, estabelecimentos médicos, estruturas de acompanhamento, consultas de adictologia ou situações que exijam um despistagem urinária rápida de várias famílias de substâncias.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eForças da ordem e instituições\u003c\/h3\u003e\n \u003cp\u003e\n O formato urinário para imersão oferece uma solução prática para atores institucionais ou profissionais que necessitem de uma ferramenta fiável, rápida e simples de usar num contexto controlado.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eAutoavaliação responsável\u003c\/h3\u003e\n \u003cp\u003e\n Os particulares podem utilizá-lo numa abordagem de autoavaliação antes de um evento importante, uma consulta médica, uma retoma de atividade ou uma iniciativa pessoal de prevenção.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eVantagens do teste Drugdiag® 6T\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eDespistagem simultânea :\u003c\/strong\u003e 6 famílias de substâncias detetadas numa única análise.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato para imersão :\u003c\/strong\u003e utilização simples, rápida e adequada para despistagens unitárias.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eLeitura visual :\u003c\/strong\u003e resultado legível em poucos minutos conforme o manual do fabricante.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante francês :\u003c\/strong\u003e dispositivo concebido pelo laboratório Toda Pharma, nº1 em testes de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade profissional :\u003c\/strong\u003e marcação CE, ambiente de qualidade ISO 13485 e rastreabilidade dos lotes.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso polivalente :\u003c\/strong\u003e empresas, saúde, instituições, prevenção e autoavaliação.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eServiço ao cliente sediado em Estrasburgo :\u003c\/strong\u003e acompanhamento AMA Prévention para a escolha e utilização dos testes.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cdiv class=\"ama-bsafe-alert\"\u003e\n \u003ch3\u003eImportante: enquadramento de utilização\u003c\/h3\u003e\n \u003cp\u003e\n Este teste destina-se a uso profissional ou pessoal responsável. Nas empresas, a sua utilização deve enquadrar-se num contexto previsto, proporcional, confidencial e conforme a legislação aplicável.\n \u003c\/p\u003e\n \u003cp\u003e\n Um resultado positivo num teste rápido deve ser considerado um resultado preliminar. Pode ser necessária uma confirmação laboratorial em qualquer contexto oficial, médico, disciplinar ou contestado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTempos urinários\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTempos de deteção urinária\u003c\/h2\u003e\n\n \u003cp\u003e\n Os tempos de deteção na urina variam muito consoante a substância, a dose, a frequência de consumo, o metabolismo, a hidratação, a função renal e o perfil individual.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis :\u003c\/strong\u003e duração indicativa muito variável consoante a frequência e intensidade do consumo.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas :\u003c\/strong\u003e duração indicativa variável conforme a molécula, dose e duração de uso.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e2 a 7 dias+\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Estas durações são indicativas. Não constituem prova absoluta de consumo ou abstinência e devem ser interpretadas em relação ao contexto e, se necessário, com confirmação biológica.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eResultado negativo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado negativo indica que as famílias pesquisadas não foram detectadas acima dos limiares do teste. Isso não garante a ausência absoluta de qualquer substância.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado positivo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado positivo indica uma reação compatível com a presença de uma ou mais famílias pesquisadas na urina. Recomenda-se confirmação em laboratório em qualquer contexto oficial, médico, disciplinar ou contestado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado inválido\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado inválido pode estar relacionado a uma má manipulação, volume insuficiente da amostra ou não cumprimento do tempo de leitura. Deve-se então repetir o teste com um novo dispositivo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualidade e confiabilidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e\n \u003cp\u003e\n O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal, permitindo uma leitura clara, rápida e adequada para usos profissionais.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConfiabilidade GC\/MS\u003c\/h3\u003e\n \u003cp\u003e\n A precisão deste dispositivo profissional de rastreio urinário foi comparada ao método de referência em laboratório, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e\n \u003cp\u003e\n Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e, um ambiente de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e rastreabilidade completa dos lotes.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003ePrincipais características\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eTipo de teste :\u003c\/strong\u003e teste urinário multi-drogas para mergulhar.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias pesquisadas :\u003c\/strong\u003e THC-COOH, COC, AMP, MET, MOP, BZO.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato :\u003c\/strong\u003e teste para mergulhar na amostra urinária.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso :\u003c\/strong\u003e prevenção profissional, saúde, instituições, acompanhamento, auto-controle.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante:\u003c\/strong\u003e laboratório francês Toda Pharma, nº1 em testes de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE e ISO 13485.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n O teste deve ser utilizado conforme o manual do fabricante. Em caso de resultado positivo, duvidoso ou contestado, recomenda-se a confirmação por análise laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eO que deteta o teste urinário Drugdiag® 6T?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Deteta 6 famílias de substâncias na urina: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMOP\u003c\/strong\u003e e \u003cstrong\u003eBZO\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \n\n \u003cdetails\u003e\n \u003csummary\u003eQual a diferença em relação a um formato cassete?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n O formato 6T é um teste para mergulhar diretamente na amostra urinária. É simples, compacto e prático para rastreios rápidos, mantendo uma leitura visual clara.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste deteta a MDMA?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não, nesta configuração a ficha indica os painéis \u003cstrong\u003eTHC-COOH, COC, AMP, MET, MOP e BZO\u003c\/strong\u003e. A MDMA não está incluída como painel distinto nesta ficha.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste é adequado para empresas?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sim, pode integrar-se numa abordagem de prevenção em postos sensíveis, respeitando o regulamento interno, a proporcionalidade, a confidencialidade e o quadro legal aplicável.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eUm resultado positivo tem valor definitivo?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não. Um teste rápido fornece um resultado analítico preliminar. Em qualquer contexto oficial, médico, judicial, administrativo, disciplinar ou contestado, recomenda-se a confirmação por método analítico de laboratório.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-cta\"\u003e\n \u003cp\u003ePrecisa de aconselhamento ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n Pedir um orçamento\n \u003c\/a\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e destina-se a uso profissional ou pessoal responsável, em conformidade com a legislação francesa e europeia em vigor. Fornece um resultado analítico preliminar e não substitui uma análise de confirmação em laboratório no âmbito de um procedimento oficial, médico, judicial, administrativo, disciplinar ou contestado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426434822468,"sku":"1046T-A","price":13.06,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426434855236,"sku":"1046T-A","price":65.3,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426434888004,"sku":"1046T-A","price":124.07,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426434920772,"sku":"1046T-A","price":277.52,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_6.png?v=1777893553"},{"product_id":"test-urinaire-10-drogues","title":"Teste Urinário 10 Drogas Drugdiag® 10T","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Drugdiag 10T urinaire\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário 10 drogas para imersão\u003c\/span\u003e\n \n \u003ch2 class=\"ama-bsafe-title\"\u003e\n Drugdiag® 10T: teste urinário multi-drogas de largo espectro\n \u003c\/h2\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n O \u003cstrong\u003eteste urinário Drugdiag® 10T\u003c\/strong\u003e, concebido pelo \u003cstrong\u003elaboratório francês Toda Pharma\u003c\/strong\u003e, nº1 em testes de diagnóstico rápido, permite a deteção simultânea de \u003cstrong\u003e10 famílias de drogas\u003c\/strong\u003e na urina.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Procura nomeadamente o \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, a \u003cstrong\u003ecocaína\u003c\/strong\u003e, as \u003cstrong\u003eanfetaminas\u003c\/strong\u003e, as \u003cstrong\u003emetanfetaminas\u003c\/strong\u003e, os \u003cstrong\u003eopiáceos\u003c\/strong\u003e, as \u003cstrong\u003ebenzodiazepinas\u003c\/strong\u003e, a \u003cstrong\u003eMDMA\u003c\/strong\u003e, os \u003cstrong\u003ebarbitúricos\u003c\/strong\u003e, a \u003cstrong\u003emetadona\u003c\/strong\u003e e os \u003cstrong\u003eantidepressivos tricíclicos\u003c\/strong\u003e.\n \u003c\/p\u003e\n \n \u003cp class=\"ama-bsafe-lead\"\u003e\n Rápido, fiável e adaptado às exigências profissionais, destina-se a \u003cstrong\u003eempresas\u003c\/strong\u003e, \u003cstrong\u003eestabelecimentos de saúde\u003c\/strong\u003e, \u003cstrong\u003eforças de segurança\u003c\/strong\u003e, estruturas médico-sociais e \u003cstrong\u003eparticulares\u003c\/strong\u003e que pretendam realizar um rastreio urinário completo numa abordagem responsável.\n \u003c\/p\u003e\n \n \u003cdiv class=\"ama-bsafe-summary-strip\"\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eDeteção simultânea de 10 famílias\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eFormato urinário para imersão\u003c\/div\u003e \u003cdiv class=\"ama-bsafe-summary-item\"\u003eEmpresa, saúde, prevenção e auto-controle\u003c\/div\u003e \u003c\/div\u003e\u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003e10 famílias alvo\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eSubstâncias detetadas\u003c\/h2\u003e\n\n \u003cp\u003e\n O Drugdiag® 10T permite uma pesquisa ampla das principais famílias de substâncias psicoativas encontradas em contextos profissionais, médicos, de dependência ou de auto-controle.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis:\u003c\/strong\u003e metabolito urinário do THC, associado ao consumo de canábis, resina, flores ou produtos contendo THC.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e50 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína:\u003c\/strong\u003e cocaína, crack e metabólitos relacionados detetáveis na urina.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas:\u003c\/strong\u003e estimulantes do tipo anfetamínico, speed e substâncias relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas:\u003c\/strong\u003e crystal meth, ice e derivados relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos:\u003c\/strong\u003e morfina, heroína, ópio e compostos relacionados.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas:\u003c\/strong\u003e Valium®, Xanax®, Temesta®, Lexomil® e moléculas relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy:\u003c\/strong\u003e MDMA, ecstasy, taz, molly e substâncias relacionadas.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e500 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbitúricos:\u003c\/strong\u003e Gardenal® e família de depressores do sistema nervoso central.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetadona:\u003c\/strong\u003e molécula utilizada nomeadamente em alguns tratamentos de substituição aos opiáceos.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e300 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAntidepressivos tricíclicos:\u003c\/strong\u003e Laroxyl® e família de medicamentos psicoativos pesquisada em certos contextos clínicos.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1000 ng\/mL\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Este teste abrange muitas moléculas associadas a estas famílias, nomeadamente Valium®, Codoliprane®, Gardenal®, Metadona®, Xanax®, Laroxyl®, Ecstasy® ou OxyContin®. Os resultados devem ser sempre interpretados de acordo com as instruções do fabricante e o contexto de utilização.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eUtilizações\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEmpresa, saúde, prevenção\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePrincipais utilizações\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003ePrevenção em empresa\u003c\/h3\u003e\n \u003cp\u003e\n O Drugdiag® 10T pode ser integrado numa abordagem de prevenção de riscos em postos sensíveis, respeitando o regulamento interno, a proporcionalidade, a confidencialidade e o enquadramento legal aplicável.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eEstabelecimentos de saúde\u003c\/h3\u003e\n \u003cp\u003e\n Este teste para imersão pode ajudar profissionais de saúde, estabelecimentos médicos, CSAPA, clínicas e estruturas médico-sociais a dispor de um indicador rápido no âmbito de um acompanhamento ou orientação.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eAcompanhamento aditológico\u003c\/h3\u003e\n \u003cp\u003e\n A presença de painéis como \u003cstrong\u003eMTD\u003c\/strong\u003e, \u003cstrong\u003eTCA\u003c\/strong\u003e, \u003cstrong\u003eBZO\u003c\/strong\u003e, \u003cstrong\u003eBAR\u003c\/strong\u003e ou \u003cstrong\u003eMOP\u003c\/strong\u003e torna este teste útil em certos contextos de acompanhamento, tratamento ou avaliação clínica.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eAuto-controle responsável\u003c\/h3\u003e\n \u003cp\u003e\n Os particulares podem utilizá-lo numa abordagem de auto-controle antes de um evento importante, uma consulta médica, uma retoma de atividade ou uma reunião profissional.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003eVantagens do teste Drugdiag® 10T\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eDespistagem ampla :\u003c\/strong\u003e 10 famílias de substâncias detetadas numa única análise.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato para imersão :\u003c\/strong\u003e utilização simples, rápida e adequada para despistagens unitárias ou controladas.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eLeitura visual :\u003c\/strong\u003e resultado legível em poucos minutos conforme o manual do fabricante.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante francês :\u003c\/strong\u003e dispositivo concebido pelo laboratório Toda Pharma, nº1 em testes de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade profissional :\u003c\/strong\u003e marcação CE, ambiente de qualidade ISO 13485 e rastreabilidade dos lotes.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso polivalente :\u003c\/strong\u003e empresas, saúde, aditologia, instituições, prevenção e auto-controle.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eServiço ao cliente sediado em Estrasburgo :\u003c\/strong\u003e acompanhamento AMA Prévention para a escolha e utilização dos testes.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cdiv class=\"ama-bsafe-alert\"\u003e\n \u003ch3\u003eImportante: enquadramento de utilização\u003c\/h3\u003e\n \u003cp\u003e\n Este teste destina-se a uso profissional ou pessoal responsável. Em empresas, a sua utilização deve enquadrar-se num contexto previsto, proporcional, confidencial e conforme a legislação aplicável.\n \u003c\/p\u003e\n \u003cp\u003e\n Um resultado positivo num teste rápido deve ser considerado um resultado preliminar. Pode ser necessária uma confirmação laboratorial em qualquer contexto oficial, médico, disciplinar ou contestado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eResultados\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTempos urinários\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTempos de deteção urinária\u003c\/h2\u003e\n\n \u003cp\u003e\n Os tempos de deteção na urina variam muito consoante a substância, dose, frequência de consumo, metabolismo, hidratação, função renal e perfil individual.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-list\"\u003e\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTHC-COOH\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCanábis :\u003c\/strong\u003e duração indicativa muito variável consoante a frequência e intensidade do consumo.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 30 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eCOC\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eCocaína :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eAMP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAnfetaminas :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMET\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetanfetaminas :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMOP\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eOpiáceos :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 4 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 4 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBZO\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBenzodiazepinas :\u003c\/strong\u003e duração indicativa variável conforme a molécula, dose e duração de uso.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e2 a 7 dias+\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMDMA\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eEcstasy :\u003c\/strong\u003e duração indicativa geralmente entre 1 e 3 dias.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 3 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eBAR\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eBarbitúricos :\u003c\/strong\u003e duração indicativa variável conforme a molécula, dose e uso.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias+\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eMTD\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eMetadona :\u003c\/strong\u003e duração indicativa variável conforme o esquema terapêutico.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias\u003c\/span\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-substance-row\"\u003e\n \u003cspan class=\"ama-bsafe-substance-code\"\u003eTCA\u003c\/span\u003e\n \u003cdiv class=\"ama-bsafe-substance-main\"\u003e\n\u003cstrong\u003eAntidepressivos tricíclicos :\u003c\/strong\u003e duração indicativa variável conforme a molécula e a posologia.\u003c\/div\u003e\n \u003cspan class=\"ama-bsafe-substance-threshold\"\u003e1 a 7 dias\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Estas durações são indicativas. Não constituem prova absoluta de consumo ou abstinência e devem ser interpretadas em relação ao contexto e, se necessário, com confirmação biológica.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eResultado negativo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado negativo indica que as famílias pesquisadas não foram detectadas acima dos limiares do teste. Isso não garante a ausência absoluta de qualquer substância.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado positivo\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado positivo indica uma reação compatível com a presença de uma ou mais famílias pesquisadas na urina. Recomenda-se confirmação laboratorial em qualquer contexto oficial, médico, disciplinar ou contestado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eResultado inválido\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Um resultado inválido pode estar relacionado a uma má manipulação, volume insuficiente de amostra ou não cumprimento do tempo de leitura. Deve-se então repetir o teste com um novo dispositivo.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTécnica\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eQualidade e fiabilidade\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eExpertise técnica\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eTecnologia de ouro coloidal\u003c\/h3\u003e\n \u003cp\u003e\n O dispositivo utiliza imunocromatografia por competição com anticorpos marcados com ouro coloidal, permitindo uma leitura clara, rápida e adequada para usos profissionais.\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eFiabilidade GC\/MS\u003c\/h3\u003e\n \u003cp\u003e\n A precisão deste dispositivo profissional de rastreio urinário foi comparada ao método de referência laboratorial, a cromatografia gasosa acoplada à espectrometria de massa (\u003cstrong\u003eGC\/MS\u003c\/strong\u003e).\n \u003c\/p\u003e\n \u003c\/article\u003e\n\n \u003carticle class=\"ama-bsafe-card\"\u003e\n \u003ch3\u003eConformidade de qualidade\u003c\/h3\u003e\n \u003cp\u003e\n Concebido pelo laboratório francês Toda Pharma, este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e, um ambiente de qualidade conforme a norma \u003cstrong\u003eISO 13485\u003c\/strong\u003e e uma rastreabilidade completa dos lotes.\n \u003c\/p\u003e\n \u003c\/article\u003e\n \u003c\/div\u003e\n\n \u003ch3\u003ePrincipais características\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eTipo de teste :\u003c\/strong\u003e teste urinário multi-drogas por imersão.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias pesquisadas :\u003c\/strong\u003e THC-COOH, COC, AMP, MET, MOP, BZO, MDMA, BAR, MTD, TCA.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato:\u003c\/strong\u003e teste para mergulhar na amostra urinária.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso:\u003c\/strong\u003e prevenção profissional, saúde, aditologia, instituições, acompanhamento e auto-controle.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricante:\u003c\/strong\u003e laboratório francês Toda Pharma, nº1 em teste de diagnóstico rápido.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE e ISO 13485.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003ch3\u003eAusência de reações cruzadas\u003c\/h3\u003e\n\n \u003cul class=\"ama-bsafe-list\"\u003e\n \u003cli\u003e\n\u003cstrong\u003eMedicamentos comuns:\u003c\/strong\u003e aspirina, ibuprofeno, paracetamol, amoxicilina, penicilina, dextrometorfano.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eSubstâncias fisiológicas e alimentares:\u003c\/strong\u003e cafeína, colesterol, hemoglobina, creatinina, vitamina C, ácido úrico.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n O teste deve ser usado conforme o manual do fabricante. Em caso de resultado positivo, duvidoso ou contestado, recomenda-se confirmação por análise laboratorial.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePerguntas Frequentes\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePerguntas frequentes\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePerguntas frequentes\u003c\/h2\u003e\n\n \u003cdiv class=\"ama-inner-accordion\"\u003e\n \u003cdetails open\u003e\n \u003csummary\u003eO que deteta o teste urinário Drugdiag® 10T?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Deteta 10 famílias de substâncias: \u003cstrong\u003eTHC-COOH\u003c\/strong\u003e, \u003cstrong\u003eCOC\u003c\/strong\u003e, \u003cstrong\u003eAMP\u003c\/strong\u003e, \u003cstrong\u003eMET\u003c\/strong\u003e, \u003cstrong\u003eMOP\u003c\/strong\u003e, \u003cstrong\u003eBZO\u003c\/strong\u003e, \u003cstrong\u003eMDMA\u003c\/strong\u003e, \u003cstrong\u003eBAR\u003c\/strong\u003e, \u003cstrong\u003eMTD\u003c\/strong\u003e e \u003cstrong\u003eTCA\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste deteta canabinoides sintéticos?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não. Esta ficha refere-se ao Drugdiag® 10T, que pesquisa 10 famílias clássicas e médico-aditológicas. Para canabinoides sintéticos como K2, K3 ou K4, deve usar-se um painel especificamente previsto para as novas drogas sintéticas.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste é adequado para empresas?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sim, pode integrar-se numa abordagem de prevenção em postos sensíveis, respeitando o regulamento interno, a proporcionalidade, a confidencialidade e o quadro legal aplicável.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eEste teste é útil em aditologia?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Sim. Os painéis MTD, TCA, BZO, BAR, MOP e outras famílias pesquisadas podem ser úteis em alguns acompanhamentos terapêuticos ou aditológicos, em complemento à avaliação clínica.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003cdetails\u003e\n \u003csummary\u003eUm resultado positivo tem valor definitivo?\u003c\/summary\u003e\n \u003cdiv class=\"ama-accordion-content\"\u003e\n \u003cp\u003e\n Não. Um teste rápido fornece um resultado analítico preliminar. Em qualquer contexto oficial, médico, judicial, administrativo, disciplinar ou contestado, recomenda-se a confirmação por método analítico de laboratório.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-cta\"\u003e\n \u003cp\u003ePrecisa de aconselhamento ou de um orçamento para uma encomenda profissional?\u003c\/p\u003e\n \u003ca href=\"https:\/\/ama-prevention.fr\/pages\/demande-de-devis\" class=\"ama-bsafe-cta-button\"\u003e\n Pedir um orçamento\n \u003c\/a\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e destina-se a uso profissional ou pessoal responsável, em conformidade com a legislação francesa e europeia em vigor. Fornece um resultado analítico preliminar e não substitui uma análise de confirmação em laboratório no âmbito de um procedimento oficial, médico, judicial, administrativo, disciplinar ou contestado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426434953540,"sku":"1040T-B","price":16.31,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426434986308,"sku":"1040T-B","price":81.55,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426435019076,"sku":"1040T-B","price":154.94,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426435051844,"sku":"1040T-B","price":346.59,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_de_face_v2.png?v=1779373751"},{"product_id":"test-urinaire-a-tremper-13-drogues","title":"Teste Urinário 13 Drogas Drugdiag® 13T - Novas Drogas de síntese","description":"\u003cstyle\u003e\n\/* =========================================================\n AMA Prévention — B-SAFE\n Accordéon premium : fermé bleu nuit \/ ouvert clair intégré\n Sans JS — prêt Shopify\n ========================================================= *\/\n\n.ama-bsafe-2026 {\n --ama-blue: #004C96;\n --ama-blue-deep: #003B78;\n --ama-blue-night: #00325f;\n --ama-orange: #FE4B09;\n --ama-text: #004C96;\n --ama-muted: #667085;\n --ama-border: #dbe6f2;\n --ama-soft: #f6f9fd;\n --ama-white: #ffffff;\n\n width: 100%;\n max-width: 1180px;\n margin: 0 auto;\n padding: 0;\n font-family: inherit;\n color: var(--ama-text);\n background: transparent !important;\n}\n\n.ama-bsafe-2026,\n.ama-bsafe-2026 * {\n box-sizing: border-box;\n}\n\n.ama-bsafe-2026 * {\n min-width: 0;\n}\n\n.ama-bsafe-panel {\n width: 100%;\n position: relative;\n overflow: hidden;\n isolation: isolate;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 28px;\n background:\n radial-gradient(circle at 88% 8%, rgba(0, 76, 150, 0.08), transparent 34%),\n radial-gradient(circle at 8% 92%, rgba(254, 75, 9, 0.04), transparent 30%),\n linear-gradient(135deg, #ffffff 0%, #f7fbff 100%);\n box-shadow:\n 0 22px 55px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.88);\n}\n\n.ama-bsafe-inner {\n width: 100%;\n padding: clamp(24px, 5vw, 52px);\n}\n\n.ama-bsafe-header {\n margin-bottom: clamp(26px, 4vw, 40px);\n}\n\n.ama-bsafe-kicker {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n margin-bottom: 14px;\n padding: 7px 12px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 12px;\n font-weight: 900;\n letter-spacing: 0.04em;\n text-transform: uppercase;\n}\n\n.ama-bsafe-kicker::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n flex-shrink: 0;\n}\n\n.ama-bsafe-title {\n margin: 0 0 16px;\n color: var(--ama-blue);\n font-size: clamp(30px, 4vw, 46px);\n line-height: 1.08;\n font-weight: 900;\n letter-spacing: -0.045em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-lead {\n margin: 0 0 16px;\n color: var(--ama-text);\n font-size: clamp(16px, 1.4vw, 18px);\n line-height: 1.72;\n}\n\n.ama-bsafe-lead strong,\n.ama-bsafe-content strong,\n.ama-bsafe-card strong,\n.ama-bsafe-substance-main strong {\n color: var(--ama-blue);\n font-weight: 850;\n}\n\n.ama-bsafe-summary-strip {\n display: flex;\n flex-wrap: wrap;\n gap: 10px;\n margin-top: 26px;\n padding: 14px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: rgba(255, 255, 255, 0.72);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-summary-item {\n display: inline-flex;\n align-items: center;\n gap: 8px;\n flex: 1 1 230px;\n padding: 10px 12px;\n border-radius: 999px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n border: 1px solid rgba(0, 76, 150, 0.10);\n color: var(--ama-blue);\n font-size: 14px;\n font-weight: 850;\n line-height: 1.35;\n}\n\n.ama-bsafe-summary-item::before {\n content: \"\";\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n flex-shrink: 0;\n}\n\n\/* =========================================================\n Accordéon principal\n Fermé : bleu nuit\n Ouvert : clair + contenu dans le même bloc\n ========================================================= *\/\n\n.ama-bsafe-accordion {\n width: 100%;\n max-width: 920px;\n margin: 0 auto;\n display: grid;\n gap: 12px;\n}\n\n.ama-bsafe-item {\n border-radius: 24px;\n overflow: hidden;\n background:\n linear-gradient(145deg, #005AAE 0%, #004C96 56%, #003B78 100%);\n border: 1px solid rgba(0, 76, 150, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.22),\n inset 0 -18px 34px rgba(0, 0, 0, 0.13),\n 0 16px 36px rgba(0, 76, 150, 0.17);\n transition:\n background 220ms ease,\n box-shadow 220ms ease,\n border-color 220ms ease;\n}\n\n.ama-bsafe-item[open] {\n background:\n radial-gradient(circle at 90% 0%, rgba(0, 76, 150, 0.055), transparent 36%),\n linear-gradient(145deg, #ffffff 0%, #f8fbff 100%);\n border-color: rgba(0, 76, 150, 0.14);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 16px 38px rgba(0, 76, 150, 0.10);\n}\n\n.ama-bsafe-item summary {\n position: relative;\n min-height: 66px;\n padding: 14px 58px 14px 18px;\n display: flex;\n align-items: center;\n cursor: pointer;\n list-style: none;\n user-select: none;\n -webkit-tap-highlight-color: transparent;\n color: #ffffff;\n}\n\n.ama-bsafe-item summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-item[open] summary {\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.92), rgba(246, 250, 255, 0.82));\n border-bottom: 1px solid rgba(0, 76, 150, 0.09);\n}\n\n.ama-bsafe-item summary::after {\n content: \"+\";\n position: absolute;\n right: 16px;\n top: 50%;\n width: 36px;\n height: 36px;\n transform: translateY(-50%);\n border-radius: 999px;\n display: inline-flex;\n align-items: center;\n justify-content: center;\n color: #ffffff;\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.22), rgba(255, 255, 255, 0.08));\n border: 1px solid rgba(255, 255, 255, 0.26);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.30),\n 0 10px 22px rgba(0, 0, 0, 0.14);\n font-size: 22px;\n font-weight: 760;\n line-height: 1;\n}\n\n.ama-bsafe-item[open] summary::after {\n content: \"−\";\n color: var(--ama-blue);\n background:\n linear-gradient(145deg, rgba(255, 255, 255, 0.98), rgba(234, 244, 255, 0.78));\n border-color: rgba(0, 76, 150, 0.10);\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.96),\n 0 8px 18px rgba(0, 76, 150, 0.10);\n font-size: 24px;\n font-weight: 700;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-item:not([open]):hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.26),\n inset 0 -18px 34px rgba(0, 0, 0, 0.14),\n 0 20px 44px rgba(0, 76, 150, 0.22);\n }\n\n .ama-bsafe-item[open]:hover {\n box-shadow:\n inset 0 1px 0 rgba(255, 255, 255, 0.98),\n 0 18px 42px rgba(0, 76, 150, 0.13);\n }\n}\n\n.ama-bsafe-acc-title {\n display: block;\n font-size: 16px;\n line-height: 1.18;\n font-weight: 800;\n letter-spacing: -0.018em;\n color: inherit;\n}\n\n.ama-bsafe-acc-sub {\n display: block;\n margin-top: 3px;\n font-size: 13px;\n line-height: 1.24;\n font-weight: 650;\n letter-spacing: -0.01em;\n color: rgba(255, 255, 255, 0.76);\n}\n\n.ama-bsafe-item[open] .ama-bsafe-acc-sub {\n color: rgba(0, 76, 150, 0.66);\n}\n\n.ama-bsafe-content {\n padding: clamp(20px, 4vw, 34px);\n background: transparent;\n animation: amaBsafeFade 220ms ease both;\n}\n\n@keyframes amaBsafeFade {\n from {\n opacity: 0;\n transform: translateY(5px);\n }\n\n to {\n opacity: 1;\n transform: translateY(0);\n }\n}\n\n\/* =========================================================\n Contenu\n ========================================================= *\/\n\n.ama-bsafe-content h2 {\n margin: 0 0 18px;\n color: var(--ama-blue);\n font-size: clamp(24px, 3vw, 36px);\n line-height: 1.10;\n font-weight: 900;\n letter-spacing: -0.04em;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-content h2::after {\n content: \"\";\n display: block;\n width: 78px;\n height: 4px;\n margin-top: 14px;\n border-radius: 999px;\n background: var(--ama-orange);\n}\n\n.ama-bsafe-content h3 {\n margin: 0 0 10px;\n color: var(--ama-blue);\n font-size: clamp(18px, 1.7vw, 23px);\n line-height: 1.18;\n font-weight: 900;\n letter-spacing: -0.03em;\n}\n\n.ama-bsafe-content p {\n margin: 0 0 18px;\n color: var(--ama-text);\n font-size: 16px;\n line-height: 1.72;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-grid {\n display: grid;\n grid-template-columns: repeat(auto-fit, minmax(260px, 1fr));\n gap: 18px;\n margin: 26px 0;\n}\n\n.ama-bsafe-card {\n position: relative;\n min-height: 150px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 22px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow-wrap: break-word;\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-card p:last-child {\n margin-bottom: 0;\n}\n\n@media (hover: hover) and (pointer: fine) {\n .ama-bsafe-card:hover,\n .ama-bsafe-substance-row:hover {\n transform: translateY(-2px);\n border-color: rgba(254, 75, 9, 0.32);\n background: #ffffff;\n box-shadow:\n 0 16px 34px rgba(0, 76, 150, 0.10),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n }\n}\n\n.ama-bsafe-substance-list {\n display: grid;\n gap: 12px;\n margin: 26px 0;\n}\n\n.ama-bsafe-substance-row {\n width: 100%;\n display: flex;\n align-items: center;\n flex-wrap: wrap;\n gap: 12px 18px;\n padding: 16px 18px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 20px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n transition:\n transform 220ms cubic-bezier(0.22, 1, 0.36, 1),\n box-shadow 220ms cubic-bezier(0.22, 1, 0.36, 1),\n border-color 220ms cubic-bezier(0.22, 1, 0.36, 1);\n}\n\n.ama-bsafe-substance-code {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 130px;\n width: 130px;\n min-width: 130px;\n max-width: 130px;\n min-height: 38px;\n padding: 7px 14px;\n border-radius: 999px;\n background: rgba(0, 76, 150, 0.08);\n color: var(--ama-blue);\n font-size: 15px;\n font-weight: 950;\n letter-spacing: -0.01em;\n text-align: center;\n}\n\n.ama-bsafe-substance-main {\n flex: 1 1 420px;\n min-width: min(100%, 320px);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.55;\n}\n\n.ama-bsafe-substance-threshold {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n flex: 0 0 auto;\n margin-left: auto;\n min-height: 34px;\n padding: 6px 12px;\n border-radius: 999px;\n background: rgba(254, 75, 9, 0.08);\n color: var(--ama-orange);\n font-size: 13px;\n font-weight: 900;\n white-space: nowrap;\n}\n\n.ama-bsafe-list {\n list-style: none;\n padding: 0;\n margin: 22px 0;\n}\n\n.ama-bsafe-list li {\n position: relative;\n padding: 15px 18px 15px 44px;\n margin-bottom: 10px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.84);\n box-shadow:\n 0 6px 18px rgba(0, 76, 150, 0.035),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n color: var(--ama-text);\n font-size: 15px;\n line-height: 1.62;\n overflow-wrap: break-word;\n}\n\n.ama-bsafe-list li::before {\n content: \"\";\n position: absolute;\n left: 18px;\n top: 22px;\n width: 8px;\n height: 8px;\n border-radius: 50%;\n background: var(--ama-orange);\n box-shadow: 0 0 0 4px rgba(254, 75, 9, 0.10);\n}\n\n.ama-bsafe-note {\n margin: 22px 0;\n padding: 18px 20px;\n border: 1px solid rgba(0, 76, 150, 0.10);\n border-radius: 18px;\n background: linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n color: var(--ama-muted);\n font-size: 14px;\n line-height: 1.62;\n font-style: italic;\n box-shadow:\n 0 8px 20px rgba(0, 76, 150, 0.04),\n inset 0 1px 0 rgba(255, 255, 255, 0.95);\n}\n\n.ama-bsafe-alert {\n margin: 28px 0;\n padding: 24px;\n border-radius: 22px;\n background:\n radial-gradient(circle at 92% 12%, rgba(255, 255, 255, 0.18), transparent 32%),\n linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n box-shadow:\n 0 16px 34px rgba(254, 75, 9, 0.22),\n inset 0 1px 0 rgba(255, 255, 255, 0.18);\n}\n\n.ama-bsafe-alert h3,\n.ama-bsafe-alert p {\n color: #ffffff;\n}\n\n.ama-bsafe-alert h3 {\n margin-bottom: 10px;\n}\n\n.ama-bsafe-alert p:last-child {\n margin-bottom: 0;\n}\n\n\/* FAQ interne *\/\n\n.ama-bsafe-faq {\n display: grid;\n gap: 12px;\n margin: 24px 0;\n}\n\n.ama-bsafe-faq details {\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 18px;\n background: rgba(255, 255, 255, 0.86);\n box-shadow:\n 0 8px 24px rgba(0, 76, 150, 0.045),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n overflow: hidden;\n}\n\n.ama-bsafe-faq summary {\n cursor: pointer;\n padding: 18px 50px 18px 18px;\n color: var(--ama-blue);\n font-weight: 900;\n line-height: 1.35;\n list-style: none;\n position: relative;\n}\n\n.ama-bsafe-faq summary::-webkit-details-marker {\n display: none;\n}\n\n.ama-bsafe-faq summary::after {\n content: \"+\";\n position: absolute;\n right: 18px;\n top: 50%;\n transform: translateY(-50%);\n color: var(--ama-orange);\n font-size: 24px;\n line-height: 1;\n font-weight: 900;\n}\n\n.ama-bsafe-faq details[open] summary::after {\n content: \"−\";\n}\n\n.ama-bsafe-faq-content {\n padding: 0 18px 18px;\n}\n\n.ama-bsafe-faq-content p:last-child {\n margin-bottom: 0;\n}\n\n.ama-bsafe-cta {\n margin-top: 30px;\n padding: 24px;\n border: 1px solid rgba(219, 230, 242, 0.95);\n border-radius: 24px;\n background:\n radial-gradient(circle at 92% 10%, rgba(0, 76, 150, 0.075), transparent 34%),\n linear-gradient(135deg, #ffffff 0%, #f8fbff 100%);\n box-shadow:\n 0 14px 34px rgba(0, 76, 150, 0.08),\n inset 0 1px 0 rgba(255, 255, 255, 0.90);\n}\n\n.ama-bsafe-cta p {\n margin-bottom: 16px;\n}\n\n.ama-bsafe-cta-button {\n display: inline-flex;\n align-items: center;\n justify-content: center;\n min-height: 46px;\n padding: 12px 22px;\n border-radius: 999px;\n background: linear-gradient(135deg, var(--ama-orange) 0%, #d63d00 100%);\n color: #ffffff !important;\n font-weight: 900;\n text-decoration: none;\n box-shadow: 0 10px 24px rgba(254, 75, 9, 0.24);\n}\n\n.ama-bsafe-legal-footer {\n margin-top: 30px;\n padding-top: 22px;\n border-top: 1px solid rgba(219, 230, 242, 0.95);\n}\n\n.ama-bsafe-legal-footer p {\n margin: 0;\n color: var(--ama-muted);\n font-size: 13px;\n line-height: 1.65;\n}\n\n\/* Validation scientifique *\/\n\n.ama-bsafe-validation {\n max-width: 1180px;\n margin: 32px auto 0;\n padding: 24px;\n border: 1px solid rgba(0, 76, 150, 0.18);\n border-radius: 22px;\n background: linear-gradient(180deg, rgba(255, 255, 255, 0.92), rgba(246, 249, 253, 0.96));\n box-shadow: 0 12px 32px rgba(0, 76, 150, 0.08);\n color: #004c96;\n}\n\n.ama-bsafe-validation-kicker {\n margin: 0 0 8px;\n font-size: 13px;\n letter-spacing: 0.08em;\n text-transform: uppercase;\n font-weight: 900;\n color: var(--ama-orange);\n}\n\n.ama-bsafe-validation h2 {\n margin: 0 0 12px;\n color: #004c96;\n font-size: clamp(22px, 2.4vw, 30px);\n line-height: 1.15;\n font-weight: 900;\n letter-spacing: -0.035em;\n}\n\n.ama-bsafe-validation p {\n margin: 0 0 10px;\n line-height: 1.65;\n color: #184b78;\n font-size: 15px;\n}\n\n.ama-bsafe-validation p:last-child {\n margin-bottom: 0;\n}\n\n\/* Responsive *\/\n\n@media (max-width: 980px) {\n .ama-bsafe-grid {\n grid-template-columns: repeat(2, minmax(0, 1fr));\n }\n\n .ama-bsafe-substance-row {\n display: grid;\n grid-template-columns: 130px minmax(0, 1fr);\n align-items: start;\n gap: 10px 14px;\n }\n\n .ama-bsafe-substance-code {\n grid-column: 1;\n grid-row: 1;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 2;\n grid-row: 1;\n justify-self: start;\n margin-left: 0;\n }\n\n .ama-bsafe-substance-main {\n grid-column: 1 \/ -1;\n grid-row: 2;\n min-width: 0;\n width: 100%;\n }\n}\n\n@media (max-width: 640px) {\n .ama-bsafe-panel {\n border-radius: 22px;\n }\n\n .ama-bsafe-inner {\n padding: 24px 14px;\n }\n\n .ama-bsafe-title {\n font-size: clamp(28px, 8.4vw, 36px);\n letter-spacing: -0.035em;\n }\n\n .ama-bsafe-summary-strip {\n display: grid;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-summary-item {\n border-radius: 16px;\n }\n\n .ama-bsafe-accordion {\n gap: 10px;\n }\n\n .ama-bsafe-item {\n border-radius: 20px;\n }\n\n .ama-bsafe-item summary {\n min-height: 60px;\n padding: 12px 52px 12px 15px;\n }\n\n .ama-bsafe-item summary::after {\n right: 14px;\n width: 32px;\n height: 32px;\n font-size: 20px;\n }\n\n .ama-bsafe-item[open] summary::after {\n font-size: 22px;\n }\n\n .ama-bsafe-acc-title {\n font-size: 15px;\n line-height: 1.18;\n letter-spacing: -0.014em;\n }\n\n .ama-bsafe-acc-sub {\n font-size: 12.2px;\n line-height: 1.22;\n }\n\n .ama-bsafe-content {\n padding: 20px 15px;\n }\n\n .ama-bsafe-content h2 {\n font-size: clamp(24px, 7vw, 30px);\n }\n\n .ama-bsafe-grid {\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-card {\n padding: 20px;\n }\n\n .ama-bsafe-substance-row {\n padding: 16px;\n grid-template-columns: 1fr;\n }\n\n .ama-bsafe-substance-code {\n width: fit-content;\n min-width: 0;\n max-width: 100%;\n }\n\n .ama-bsafe-substance-threshold {\n grid-column: 1;\n grid-row: auto;\n }\n\n .ama-bsafe-validation {\n padding: 20px;\n border-radius: 20px;\n }\n}\n\u003c\/style\u003e\n\u003csection class=\"ama-bsafe-2026\" aria-label=\"Fiche produit Test Urinaire 13 Drogues Drugdiag® 13T\"\u003e\n \u003cdiv class=\"ama-bsafe-panel\"\u003e\n \u003cdiv class=\"ama-bsafe-inner\"\u003e\n \u003cheader class=\"ama-bsafe-header\"\u003e\n \u003cspan class=\"ama-bsafe-kicker\"\u003eTeste urinário profissional\u003c\/span\u003e\n \u003ch2 class=\"ama-bsafe-title\"\u003eTeste Urinário 13 Drogas Drugdiag® 13T\u003c\/h2\u003e\n \u003cdiv class=\"ama-bsafe-lead\"\u003e\n \u003cp style=\"font-size: 17px; line-height: 1.8; margin-bottom: 15px;\"\u003e\n O \u003cstrong\u003eteste urinário Drugdiag® T13\u003c\/strong\u003e é um dispositivo de rastreio multi-drogas que permite pesquisar simultaneamente \u003cstrong\u003e13 famílias de substâncias\u003c\/strong\u003e na urina. Foi concebido para profissionais de saúde, empresas, estruturas de prevenção e particulares que queiram realizar um controlo rápido, fiável e fácil de interpretar.\n \u003c\/p\u003e\n\n \u003cp style=\"font-size: 16px; line-height: 1.7; margin: 0;\"\u003e\n Este teste não deteta drogas sintéticas do tipo 3-MMC, 4-MMC, 2-MMC, PTC \/ Buddha Blue, MDPV ou α-PVP. O Drugdiag® T13 foca-se precisamente nas seguintes famílias: \u003cstrong\u003eTHC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML e FYL\u003c\/strong\u003e.\n \u003c\/p\u003e\n\n \u003ch3 style=\"color: #004C96;\"\u003e🧪 Substâncias detetadas pelo Drugdiag® T13:\u003c\/h3\u003e\n \u003cul\u003e\n \u003cli\u003e\n\u003cstrong\u003eTHC:\u003c\/strong\u003e cannabis \/ THC-COOH.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eAMP:\u003c\/strong\u003e anfetaminas.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eBAR:\u003c\/strong\u003e barbitúricos.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eBZO:\u003c\/strong\u003e benzodiazepinas.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eBUP:\u003c\/strong\u003e buprenorfina.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eCOC:\u003c\/strong\u003e cocaína.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMDMA:\u003c\/strong\u003e ecstasy.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMET:\u003c\/strong\u003e metanfetaminas.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMTD:\u003c\/strong\u003e metadona.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eMOP:\u003c\/strong\u003e opiáceos \/ morfina.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eTCA:\u003c\/strong\u003e antidepressivos tricíclicos.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eTML:\u003c\/strong\u003e tramadol.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFYL:\u003c\/strong\u003e fentanil.\u003c\/li\u003e\n \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/header\u003e\n \u003cdiv class=\"ama-bsafe-accordion\"\u003e\n \u003cdetails class=\"ama-bsafe-item\" open\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003ePor que escolher o teste urinário Drugdiag® T13?\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003ePor que escolher o teste urinário Drugdiag® T13? Rastreio amplo numa única análise…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003ePor que escolher o teste urinário Drugdiag® T13?\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003cdiv class=\"ama-bsafe-card\"\u003e\n \u003ch3 style=\"margin-top: 0;\"\u003eRastreio amplo numa única análise\u003c\/h3\u003e\n \u003cp style=\"margin-bottom: 0;\"\u003e\n O Drugdiag® T13 permite controlar 13 famílias de substâncias com um único dispositivo. É especialmente útil quando é necessário um rastreio urinário completo, nomeadamente em contextos profissionais, médicos, preventivos ou pessoais.\n \u003c\/p\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-card\"\u003e\n \u003ch3 style=\"margin-top: 0;\"\u003eLeitura rápida e simples\u003c\/h3\u003e\n \u003cp style=\"margin-bottom: 10px;\"\u003e\n O teste foi concebido para uma utilização prática: recolha de urina, contacto com a amostra, seguida de leitura visual do resultado em poucos minutos conforme as indicações do folheto.\n \u003c\/p\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-card\"\u003e\n \u003ch3 style=\"margin-top: 0;\"\u003eSolução profissional\u003c\/h3\u003e\n \u003cp style=\"margin-bottom: 0;\"\u003e\n Adaptado a empresas, profissionais de saúde, estruturas de prevenção e particulares, este teste oferece uma solução fiável para identificar rapidamente a presença possível de substâncias frequentemente pesquisadas.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eOs pontos fortes do Drugdiag® T13\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eOs pontos fortes do Drugdiag® T13 13 famílias pesquisadas: THC, AMP, BAR, BZO, BUP,…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eOs pontos fortes do Drugdiag® T13\u003c\/h2\u003e\n\u003cul\u003e\n \u003cli\u003e\n\u003cstrong\u003e13 famílias pesquisadas:\u003c\/strong\u003e THC, AMP, BAR, BZO, BUP, COC, MDMA, MET, MTD, MOP, TCA, TML e FYL.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFormato urinário:\u003c\/strong\u003e adaptado à deteção de numerosos metabólitos eliminados na urina.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eResultado rápido:\u003c\/strong\u003e leitura visual em poucos minutos conforme o protocolo de utilização.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eUso versátil:\u003c\/strong\u003e empresas, saúde, prevenção, coletividades, estruturas especializadas e auto-controle.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eFabricação francesa:\u003c\/strong\u003e dispositivo da gama Drugdiag® do laboratório Toda Pharma.\u003c\/li\u003e\n \u003cli\u003e\n\u003cstrong\u003eQualidade profissional:\u003c\/strong\u003e dispositivo médico de diagnóstico in vitro com marcação CE.\u003c\/li\u003e\n \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eTabela das 13 famílias detetadas\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eTabela das 13 famílias detetadas O Drugdiag® T13 não deve ser confundido com um…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eTabela das 13 famílias detetadas\u003c\/h2\u003e\n\u003cp\u003e\n O Drugdiag® T13 não deve ser confundido com um teste específico para novas drogas sintéticas. Pesquisa as seguintes famílias de substâncias:\n \u003c\/p\u003e\n\n \u003ctable style=\"width: 100%;\" class=\"ama-bsafe-table\"\u003e\n \u003cthead\u003e\n \u003ctr\u003e\n \u003cth style=\"width: 25%;\"\u003eCódigo\u003c\/th\u003e\n \u003cth style=\"width: 35%;\"\u003eFamília detetada\u003c\/th\u003e\n \u003cth style=\"width: 40%;\"\u003eExemplos \/ uso da deteção\u003c\/th\u003e\n \u003c\/tr\u003e\n \u003c\/thead\u003e\n \u003ctbody\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eTHC\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eCannabis\u003c\/td\u003e\n \u003ctd\u003ePesquisa de THC-COOH, principal metabólito da cannabis na urina.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eAMP\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eAnfetaminas\u003c\/td\u003e\n \u003ctd\u003eDeteção de anfetaminas e substâncias relacionadas conforme os limiares do teste.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eBAR\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eBarbitúricos\u003c\/td\u003e\n \u003ctd\u003ePesquisa de barbitúricos, substâncias sedativas hoje menos comuns mas ainda monitorizadas.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eBZO\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eBenzodiazepinas\u003c\/td\u003e\n \u003ctd\u003eFamília de medicamentos ansiolíticos, hipnóticos ou sedativos que podem alterar a vigilância.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eBUP\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eBuprenorfina\u003c\/td\u003e\n \u003ctd\u003ePesquisa de buprenorfina, especialmente no âmbito do acompanhamento ou controlo de substâncias opioides.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eCOC\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eCocaína\u003c\/td\u003e\n \u003ctd\u003eDeteção de cocaína e seus metabólitos urinários.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eMDMA\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eEcstasy\u003c\/td\u003e\n \u003ctd\u003ePesquisa de MDMA, substância estimulante frequentemente associada ao ambiente festivo.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eMET\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eMetanfetaminas\u003c\/td\u003e\n \u003ctd\u003eDeteção de metanfetaminas conforme os limiares previstos pelo dispositivo.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eMTD\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eMetadona\u003c\/td\u003e\n \u003ctd\u003ePesquisa de metadona, especialmente em contextos de acompanhamento ou controlo de opioides.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eMOP\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eOpiáceos \/ morfina\u003c\/td\u003e\n \u003ctd\u003eDeteção de opiáceos naturais e relacionados, conforme o desempenho do teste.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eTCA\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eAntidepressivos tricíclicos\u003c\/td\u003e\n \u003ctd\u003ePesquisa de TCA, família de medicamentos que pode ser monitorizada em certos contextos clínicos.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eTML\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eTramadol\u003c\/td\u003e\n \u003ctd\u003eDeteção de tramadol, analgésico opioide que pode alterar a vigilância e apresentar riscos de uso indevido.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003ctr\u003e\n \u003ctd\u003e\u003cstrong\u003eFYL\u003c\/strong\u003e\u003c\/td\u003e\n \u003ctd\u003eFentanyl\u003c\/td\u003e\n \u003ctd\u003ePesquisa de fentanyl, opioide potente que requer vigilância especial em contextos de prevenção e saúde.\u003c\/td\u003e\n \u003c\/tr\u003e\n \u003c\/tbody\u003e\n \u003c\/table\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n As famílias detetadas devem ser sempre verificadas com o folheto do produto e os limiares indicados pelo fabricante. Um teste rápido fornece um resultado orientativo; em caso de dúvida, o resultado deve ser confirmado por uma análise laboratorial.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-alert\"\u003e\n \u003ch3\u003e⚠️ Importante: este teste não deteta drogas sintéticas específicas\u003c\/h3\u003e\n \u003cp\u003e\n O Drugdiag® T13 não deve ser apresentado como um teste de deteção de catinonas sintéticas ou canabinoides sintéticos.\n \u003c\/p\u003e\n \u003cp\u003e\n Não é direcionado especificamente para substâncias como a \u003cstrong\u003e3-MMC\u003c\/strong\u003e, a \u003cstrong\u003e4-MMC\u003c\/strong\u003e, a \u003cstrong\u003e2-MMC\u003c\/strong\u003e, o \u003cstrong\u003ePTC \/ Buddha Blue\u003c\/strong\u003e, o \u003cstrong\u003eMDPV\u003c\/strong\u003e ou o \u003cstrong\u003eα-PVP\u003c\/strong\u003e.\n \u003c\/p\u003e\n \u003cp\u003e\n Para pesquisar estas substâncias, é necessário usar um teste adaptado às novas substâncias psicoativas e às drogas sintéticas.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eEm que casos utilizar o Drugdiag® T13?\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEm que casos utilizar o Drugdiag® T13? Empresas e prevenção O teste pode ser…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eEm que casos utilizar o Drugdiag® T13?\u003c\/h2\u003e\n\u003cdiv class=\"ama-bsafe-grid\"\u003e\n \u003cdiv class=\"ama-bsafe-card\"\u003e\n \u003ch3 style=\"margin-top: 0;\"\u003eEmpresas e prevenção\u003c\/h3\u003e\n \u003cp style=\"margin-bottom: 0;\"\u003e\n O teste pode ser integrado numa abordagem de prevenção de riscos nas empresas, especialmente para postos de segurança ou ambientes sensíveis, respeitando o quadro legal aplicável, o regulamento interno e a confidencialidade dos resultados.\n \u003c\/p\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-card\"\u003e\n \u003ch3 style=\"margin-top: 0;\"\u003eProfissionais de saúde\u003c\/h3\u003e\n \u003cp style=\"margin-bottom: 0;\"\u003e\n Constitui uma ferramenta de deteção rápida para orientar um acompanhamento, um seguimento ou um pedido de confirmação biológica quando o contexto clínico o exigir.\n \u003c\/p\u003e\n \u003c\/div\u003e\n\n \u003cdiv class=\"ama-bsafe-card\"\u003e\n \u003ch3 style=\"margin-top: 0;\"\u003eParticulares e auto-controle\u003c\/h3\u003e\n \u003cp style=\"margin-bottom: 0;\"\u003e\n O Drugdiag® T13 pode ser utilizado por particulares que desejem realizar um auto-controle urinário amplo, com uma leitura simples e rápida do resultado.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eDeteção, prevenção e submissão química\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eDeteção, prevenção e submissão química O Drugdiag® T13 pode contribuir para uma…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eDeteção, prevenção e submissão química\u003c\/h2\u003e\n\u003cp\u003e\n O Drugdiag® T13 pode contribuir para uma abordagem de prevenção ampla, especialmente quando é necessário pesquisar várias famílias de substâncias como benzodiazepinas, opiáceos, tramadol, fentanil, metadona, cocaína, anfetaminas ou cannabis.\n \u003c\/p\u003e\n\n \u003cp\u003e\n No entanto, não permite a deteção de todas as substâncias que possam estar envolvidas numa situação de submissão química. Não substitui um acompanhamento médico, uma apresentação de queixa nem uma análise toxicológica especializada realizada por um laboratório.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eConteúdo do saco\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eConteúdo do saco O produto está embalado para garantir uma utilização simples e…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eConteúdo do saco\u003c\/h2\u003e\n\u003cp\u003e\n O produto está embalado para garantir uma utilização simples e higiénica:\n \u003c\/p\u003e\n\n \u003cul\u003e\n \u003cli\u003e1 teste urinário Drugdiag® T13.\u003c\/li\u003e\n \u003cli\u003e1 instruções de utilização conforme a embalagem do fabricante.\u003c\/li\u003e\n \u003cli\u003eResultado legível diretamente no dispositivo após a realização do teste.\u003c\/li\u003e\n \u003c\/ul\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eEspecialização clínica \u0026amp; qualidade do dispositivo\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eEspecialização clínica \u0026amp; qualidade do dispositivo Tecnologia de rastreio rápido O Drugdiag®…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eEspecialização clínica \u0026amp; qualidade do dispositivo\u003c\/h2\u003e\n\u003ch3\u003eTecnologia de rastreio rápido\u003c\/h3\u003e\n \u003cp\u003e\n O Drugdiag® T13 baseia-se numa tecnologia imunocromatográfica que permite pesquisar rapidamente a presença possível de várias famílias de substâncias numa amostra urinária.\n \u003c\/p\u003e\n\n \u003ch3\u003eDispositivo médico de diagnóstico in vitro\u003c\/h3\u003e\n \u003cp\u003e\n Este teste é um dispositivo médico de diagnóstico \u003ci\u003ein vitro\u003c\/i\u003e. Possui a marcação \u003cstrong\u003eCE\u003c\/strong\u003e ao abrigo da regulamentação aplicável aos dispositivos de diagnóstico.\n \u003c\/p\u003e\n\n \u003ch3\u003eFabricação francesa e qualidade Toda Pharma\u003c\/h3\u003e\n \u003cp\u003e\n O Drugdiag® T13 pertence à gama Drugdiag® do laboratório francês \u003cstrong\u003eToda Pharma\u003c\/strong\u003e, um ator reconhecido no teste de diagnóstico rápido. Insere-se numa exigência de qualidade profissional adaptada aos usos de rastreio, prevenção e saúde.\n \u003c\/p\u003e\n\n \u003cdiv class=\"certifications\"\u003e\n \u003cspan class=\"cert-badge\"\u003eCE\u003c\/span\u003e\n \u003cspan class=\"cert-badge\"\u003eDiagnóstico in vitro\u003c\/span\u003e\n \u003cspan class=\"cert-badge\"\u003eToda Pharma\u003c\/span\u003e\n \u003cspan class=\"cert-badge\"\u003eFabricação francesa\u003c\/span\u003e\n \u003cspan class=\"cert-badge\"\u003eUso profissional\u003c\/span\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003cdetails class=\"ama-bsafe-item\"\u003e\n \u003csummary\u003e\n \u003cspan\u003e\n \u003cspan class=\"ama-bsafe-acc-title\"\u003eConselhos de utilização\u003c\/span\u003e\n \u003cspan class=\"ama-bsafe-acc-sub\"\u003eConselhos de utilização Leia atentamente as instruções antes de usar. Utilize um…\u003c\/span\u003e\n \u003c\/span\u003e\n \u003c\/summary\u003e\n \u003cdiv class=\"ama-bsafe-content\"\u003e\n \u003ch2\u003eConselhos de utilização\u003c\/h2\u003e\n\u003cul\u003e\n \u003cli\u003eLeia atentamente as instruções antes de usar.\u003c\/li\u003e\n \u003cli\u003eUtilize uma amostra urinária limpa, em condições adequadas.\u003c\/li\u003e\n \u003cli\u003eRespeite o tempo de leitura indicado pelo fabricante.\u003c\/li\u003e\n \u003cli\u003eNão interprete o resultado para além do prazo recomendado.\u003c\/li\u003e\n \u003cli\u003eEm caso de resultado positivo, duvidoso ou contestado, solicite uma confirmação em laboratório.\u003c\/li\u003e\n \u003c\/ul\u003e\n\n \u003cp class=\"ama-bsafe-note\"\u003e\n Um teste urinário rápido é uma ferramenta de rastreio e orientação. Não constitui por si só uma prova médico-legal definitiva. Para qualquer decisão médica, profissional ou jurídica, pode ser necessária uma confirmação por análise toxicológica.\n \u003c\/p\u003e\n\n \u003cdiv class=\"ama-bsafe-legal-footer\"\u003e\n \u003cp\u003e\n \u003cstrong\u003eMenções legais :\u003c\/strong\u003e Este dispositivo médico é um produto de saúde regulamentado que, ao abrigo desta regulamentação, possui a marcação CE. Em caso de tratamento médico, resultado positivo, dúvida na interpretação ou situação de risco, consulte um profissional de saúde ou um laboratório de análises clínicas.\n \u003c\/p\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/details\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n \u003c\/div\u003e\n\u003c\/section\u003e","brand":"Laboratoire Toda Pharma","offers":[{"title":"1 unidade","offer_id":56426435117380,"sku":"10413T-A-1","price":25.9,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 5","offer_id":56426435150148,"sku":"10413T-A-1","price":129.5,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 10","offer_id":56426435182916,"sku":"10413T-A-1","price":246.05,"currency_code":"EUR","in_stock":true},{"title":"Conjunto de 25","offer_id":56426435215684,"sku":"10413T-A-1","price":550.38,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0634\/1335\/4734\/files\/photo_produit_drugdiag_T_de_face_v2.png?v=1779373751"}],"url":"https:\/\/ama-prevention.com\/pt-pt\/collections\/testes-urinarios-drugdiag-t.oembed","provider":"AMA Prévention ","version":"1.0","type":"link"}